1. Baldessarini, R.J., Cohen, B.M., and Teicher, M.H. (1988): Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Archives of General Psychiatry 45: 79–91
2. Barnes, T.R., and Curson, D.A. (1994): Long-term depot antipsychotics. A riskbenefit assessment. Drug Safety 10: 464–479
3. Bitter, I., Volavka, J., and Scheurer, J. (1991): The concept of the neuroleptic threshold: An update. Journal of Clinical Psychopharmacology 11: 28–33
4. Carpenter, W.T.J, Stevens, J.H., and Rey, A.C. (1992): Early intervention vs. continuous pharmacotherapy in schizophrenia. Psychopharmacological Bulletin 18: 21–23
5. Carpenter, W.T.J., Heinrichs, D.W., and Alphs, L.D. (1985): Treatment of negative symptoms. Schizophrenia Bulletin 11: 440–452